Washington Homeopathic Products Kali Sulphuricum fails identification test
Washington Homeopathic Products is recalling Kali Sulphuricum 3X homeopathic medicine nationwide because identification testing using HPTLC analysis produced out-of-specification results.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a homeopathic medicine with failed identification testing. No illnesses, injuries, or deaths are reported in the source text. The hazard is test-result-based rather than tied to documented harm, and homeopathic products present lower inherent risk than conventional pharmaceuticals, placing this in the Moderate category.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Kali Sulphuricum 3X, 960 mL bottles containing 20% alcohol (Lot #29475, expiration 8/17/2026), manufactured for use in further manufacturing. The product was distributed nationwide in the USA.
The recall was initiated because identification testing based on HPTLC (high-performance thin-layer chromatography) analysis produced out-of-specification test results. This means the product did not meet the required standards for identity verification through this analytical method.
Consumers and healthcare practitioners in possession of this product should discontinue use and contact Washington Homeopathic Products for instructions on return or destruction of affected bottles.
The recalled product
- Product
- Kali Sulphuricum 3X, 960ml 20% Alcohol, WHP Homeopathic Medicine, For Manufacturing Use Only. Manufactured by Washington Homeopathic Products 260JR hawvermale Way Berkeley Springs WV 25411.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- failed-identification-testing
- out-of-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 29475
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27